Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling.

Liu BA, Jablonowski K, Raina M, Arcé M, Pawson T, Nash PD.

Mol Cell. 2006 Jun 23;22(6):851-68.

2.

The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.

Liu BA, Shah E, Jablonowski K, Stergachis A, Engelmann B, Nash PD.

Sci Signal. 2011 Dec 6;4(202):ra83. doi: 10.1126/scisignal.2002105.

3.

L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.

Ye B, Akamatsu M, Shoelson SE, Wolf G, Giorgetti-Peraldi S, Yan X, Roller PP, Burke TR Jr.

J Med Chem. 1995 Oct 13;38(21):4270-5.

PMID:
7473554
4.

High-throughput phosphotyrosine profiling using SH2 domains.

Machida K, Thompson CM, Dierck K, Jablonowski K, Kärkkäinen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, Pawson T, Renkema GH, Saksela K, Schiller MR, Shin DG, Mayer BJ.

Mol Cell. 2007 Jun 22;26(6):899-915.

5.

SH2 and PTB domains in tyrosine kinase signaling.

Schlessinger J, Lemmon MA.

Sci STKE. 2003 Jul 15;2003(191):RE12. Review.

PMID:
12865499
6.

Molecular recognition by SH2 domains.

Bradshaw JM, Waksman G.

Adv Protein Chem. 2002;61:161-210. Review.

PMID:
12461824
7.

Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Eck MJ, Shoelson SE, Harrison SC.

Nature. 1993 Mar 4;362(6415):87-91.

PMID:
7680435
8.

Evolution of SH2 domains and phosphotyrosine signalling networks.

Liu BA, Nash PD.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2556-73. doi: 10.1098/rstb.2012.0107. Review.

9.

Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.

Burke TR Jr, Yao ZJ, Liu DG, Voigt J, Gao Y.

Biopolymers. 2001;60(1):32-44. Review.

PMID:
11376431
10.

A remote substrate docking mechanism for the tec family tyrosine kinases.

Joseph RE, Min L, Xu R, Musselman ED, Andreotti AH.

Biochemistry. 2007 May 8;46(18):5595-603. Epub 2007 Apr 17.

PMID:
17439160
11.

Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.

Bradshaw JM, Mitaxov V, Waksman G.

J Mol Biol. 1999 Nov 5;293(4):971-85.

PMID:
10543978
12.
13.

Src homology-2 domains: structure, mechanisms, and drug discovery.

Sawyer TK.

Biopolymers. 1998;47(3):243-61. Review.

PMID:
9817027
14.

Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

Wagner MJ, Stacey MM, Liu BA, Pawson T.

Cold Spring Harb Perspect Biol. 2013 Dec 1;5(12):a008987. doi: 10.1101/cshperspect.a008987. Review.

15.

Profiling the global tyrosine phosphorylation state.

Machida K, Mayer BJ, Nollau P.

Mol Cell Proteomics. 2003 Apr;2(4):215-33. Epub 2003 May 17. Review.

16.

The SH2 domain: versatile signaling module and pharmaceutical target.

Machida K, Mayer BJ.

Biochim Biophys Acta. 2005 Feb 14;1747(1):1-25. Epub 2004 Nov 19. Review.

PMID:
15680235
17.

Structural basis for the requirement of two phosphotyrosine residues in signaling mediated by Syk tyrosine kinase.

Groesch TD, Zhou F, Mattila S, Geahlen RL, Post CB.

J Mol Biol. 2006 Mar 10;356(5):1222-36. Epub 2005 Dec 27.

PMID:
16410013
18.
19.

Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70.

García-Echeverria C.

Curr Med Chem. 2001 Nov;8(13):1589-604. Review.

PMID:
11562287
20.

Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.

Folmer RH, Geschwindner S, Xue Y.

Biochemistry. 2002 Dec 3;41(48):14176-84.

PMID:
12450381

Supplemental Content

Support Center